Pierre-Olivier Gaudreau MD PhD
@DrPOGaudreau
Followers
180
Following
99
Statuses
40
Assistant Professor. Medical Oncologist. CCTG Senior Investigator (Thoracic Oncology and Investigational New Drug). @queensu @INDProgramCCTG @CDNCancerTrials
Joined March 2021
RT @CDNCancerTrials: Dr. Joseph Pater #CCTG's founding director recognized for a lifetime of work in cancer research with his appointment a…
0
21
0
(3/3) As well as the CCTG IND trial poster for the IND.238 trial (Dr. Peter Ellis & Dr. Sara Taylor): Time: Jun/3/2023, 8:00 AM-11:00 AM CDT Hall A @INDProgramCCTG @CDNCancerTrials
#immunotherapy #rechallenge #immunerelatedadverseevent
0
2
6
(2/3) I also invite you to visit our CCTG IND trial posters at ASCO, including IND.240 (Dr. Helen MacKay): Time: Jun/5/2023, 1:15 PM CDT Hall A @INDProgramCCTG @CDNCancerTrials
#immunotherapy #ovariancancer
0
3
5
(1/3) Going to ASCO this week? Join us for Dr. Quincy Chu's oral presentation highlighting the phase 3 results of the IND.227 trial in mesothelioma: Time: Jun/3/2023, 3:00 PM-6:00 PM CDT Hall B1 @INDProgramCCTG @CDNCancerTrials #mesothelioma
0
7
14
RT @QueensCRI: Pleased to announce our June seminar speaker! Dr. Caroline Lamarche @lamarchecaroli1 will be presenting via Zoom on June 5th…
0
2
0
@CJTsaiMDPhD @rweichselbaum @RohanKatipally @SeanPitroda @JYangMDPhD @xrtGenomics @IyengarPuneeth Thanks for sharing, Jillian. Very interesting - and aligned with my prior pre-clinical training at MD Anderson (credits to my mentor Dr. Don L. Gibbons, internationally recognized for his work on tumor plasticity and EMT in the context of thoracic malignancies).
0
0
4
RT @JustinGainor: (1/3) Excited to share our work on genomic and transcriptomic predictors of response to PD-(L)1 inhibitors in NSCLC @Natu…
0
64
0
RT @UNESCO_fr: Libérer le potentiel des femmes = libérer le potentiel de l’humanité ! ✨ En cette #JournéeDesFemmes, réclamons un monde dig…
0
24
0
@CDNCancerTrials’s IND.227 phase 2 results comparing front-line IO vs CT vs IO + CT in advanced pleural mesothelioma are now available @JTOonline. Many thanks to the patients and their families, as well as to our team and all participating centres.
0
2
8
RT @UNESCO: Happy #WomenInScience Day! Let us get rid of stereotypes, challenge gender bias and beat discrimination that hold women & girl…
0
677
0
RT @CDNCancerTrials: #CCTG is looking for a Patient Representative Volunteer to support the Lung Disease Site Committee & represent the per…
0
3
0
RT @StephenVLiu: Dr. @DrJNaidoo discusses resistance to immunotherapy- important to have consistent terminology. Highlights importance of t…
0
8
0
Very promising work from our colleagues at McGill, using AI to predict early-stage NSCLC recurrence following surgery. Congratulations to the whole team! @sori_mark @loganwalsh @DanielaQuail @DoctorJspicer @PJoubertPatho @Miranda_WYu
0
1
1
@loganawalsh @Nature Very happy to see these papers published from such a great team. Congratulations!
0
0
3
RT @3ctnNews: Deeply saddened by news of Jill Hamer-Wilson’s passing. As a Patient Partner, Jill devoted her time and experience to clinica…
0
6
0
RT @jitcancer: Review: iRECIST and atypical patterns of response to immuno-oncology drugs #JITC @DrPOGaudreau 3/4 h…
0
2
0
RT @CDNCancerTrials: #CCTG recognizes #Immune2Cancer Day and our partnership with @CancerResearch - working together to conduct the clinica…
0
6
0
RT @CDNCancerTrials: Canadian Cancer Stats 2022 has been released by @cancersociety @StatCan_eng @GovCanHealth The published paper can seen…
0
2
0